Interferon-λ cures persistent murine norovirus infection in the absence of adaptive immunity.

Journal: Science (New York, N.Y.)
Published:
Abstract

Norovirus gastroenteritis is a major public health burden worldwide. Although fecal shedding is important for transmission of enteric viruses, little is known about the immune factors that restrict persistent enteric infection. We report here that although the cytokines interferon-α (IFN-α) and IFN-β prevented the systemic spread of murine norovirus (MNoV), only IFN-λ controlled persistent enteric infection. Infection-dependent induction of IFN-λ was governed by the MNoV capsid protein and correlated with diminished enteric persistence. Treatment of established infection with IFN-λ cured mice in a manner requiring nonhematopoietic cell expression of the IFN-λ receptor, Ifnlr1, and independent of adaptive immunity. These results suggest the therapeutic potential of IFN-λ for curing virus infections in the gastrointestinal tract.

Authors
Timothy Nice, Megan Baldridge, Broc Mccune, Jason Norman, Helen Lazear, Maxim Artyomov, Michael Diamond, Herbert Virgin
Relevant Conditions

Viral Gastroenteritis